These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 21568961)

  • 1. Treatment of taunting behavior in vascular dementia with valproic acid.
    Stewart JT; Poetter CE
    J Am Geriatr Soc; 2011 May; 59(5):929-30. PubMed ID: 21568961
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of impulsivity and aggression in a patient with vascular dementia.
    Buchalter EN; Lantz MS
    Geriatrics; 2001 Feb; 56(2):53-4. PubMed ID: 11219025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sodium valproate on behavioral disturbances in elderly outpatients with dementia.
    Mizukami K; Hatanaka K; Ishii T; Iwakiri M; Sodeyama N; Tanaka Y; Asada T
    Geriatr Gerontol Int; 2010 Oct; 10(4):324-6. PubMed ID: 20887626
    [No Abstract]   [Full Text] [Related]  

  • 4. [Good effect of valproate against aggression in Huntington disease. Only two cases reported earlier].
    Rask G; Andersson C
    Lakartidningen; 2010 Dec 1-7; 107(48):3060-1. PubMed ID: 21287753
    [No Abstract]   [Full Text] [Related]  

  • 5. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative medicine. Achieving balance between herbal remedies and medical therapy.
    Rhodes-Kropf J; Lantz MS;
    Geriatrics; 2001 Aug; 56(8):44-7. PubMed ID: 11505860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium valproate in the treatment of aggressive behavior in patients with dementia--a randomized placebo controlled clinical trial.
    Sival RC; Haffmans PM; Jansen PA; Duursma SA; Eikelenboom P
    Int J Geriatr Psychiatry; 2002 Jun; 17(6):579-85. PubMed ID: 12112183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of valproic acid in the treatment of borderline personality disorder].
    Hirschman S; Dolberg OT; Stern L; Grunhaus LJ
    Harefuah; 1997 Sep; 133(5-6):205-8. PubMed ID: 9461692
    [No Abstract]   [Full Text] [Related]  

  • 9. Schizophrenia and valproate.
    Citrome L
    Psychopharmacol Bull; 2003; 37 Suppl 2():74-88. PubMed ID: 15021863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of divalproex on disruptive behavior of jail inmates.
    Lawson WB; Nanos J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):909-10. PubMed ID: 18055083
    [No Abstract]   [Full Text] [Related]  

  • 11. Low dose of sodium divalproate for the treatment of migraine.
    Fragoso YD
    MedGenMed; 2003 Mar; 5(1):32. PubMed ID: 12827093
    [No Abstract]   [Full Text] [Related]  

  • 12. Divalproex sodium in the treatment of aggressive behavior and dysphoria in patients with organic brain syndromes.
    Horne M; Lindley SE
    J Clin Psychiatry; 1995 Sep; 56(9):430-1. PubMed ID: 7665542
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inadequate vasopressin secretion and valproate].
    Franco Hidalgo S; Prieto de Paula JM; Salado Valdivieso I
    Endocrinol Nutr; 2009 May; 56(5):277. PubMed ID: 19627751
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous valproate treatment: some observations.
    Duggal HS
    Can J Psychiatry; 2002 Feb; 47(1):96. PubMed ID: 11873717
    [No Abstract]   [Full Text] [Related]  

  • 15. Valproic acid treatment of episodic explosiveness related to brain injury.
    Geracioti TD
    J Clin Psychiatry; 1994 Sep; 55(9):416-7. PubMed ID: 7929025
    [No Abstract]   [Full Text] [Related]  

  • 16. Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms.
    Zink M; Englisch S; Knopf U; Kuwilsky A; Dressing H
    Pharmacopsychiatry; 2007 Sep; 40(5):202-3. PubMed ID: 17874353
    [No Abstract]   [Full Text] [Related]  

  • 17. Risperidone as an adjunct to valproic acid.
    Waring EW; Dewan VK; Cohen D; Grewal R
    Can J Psychiatry; 1999 Mar; 44(2):189. PubMed ID: 10097843
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
    Buckley PF; Paulsson B; Brecher M
    J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of endogenous depressions with valpromide (open study).
    Svestka J; Rysánek R; Cesková E
    Homeost Health Dis; 1991; 33(5-6):291-2. PubMed ID: 18265503
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation and management of aggressive behavior in the elderly demented patient.
    Raskind MA
    J Clin Psychiatry; 1999; 60 Suppl 15():45-9. PubMed ID: 10418815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.